Filing Details
- Accession Number:
- 0001104659-19-037468
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-06-25 19:03:23
- Reporting Period:
- 2019-06-21
- Accepted Time:
- 2019-06-25 19:03:23
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1658247 | Crinetics Pharmaceuticals Inc. | CRNX | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1219014 | M Scott Rocklage | 501 2Nd Street, Suite 350 San Francisco, CA 94107 | No | No | No | Yes | |
1240357 | D John Diekman | 501 2Nd Street, Suite 350 San Francisco, CA 94107 | No | No | No | Yes | |
1589314 | 5Am Partners Iv, Llc | 501 2Nd Street, Suite 350 San Francisco, CA 94107 | No | No | No | Yes | |
1589315 | 5Am Ventures Iv, L.p. | 501 2Nd Street, Suite 350 San Francisco, CA 94107 | No | No | No | Yes | |
1593361 | 5Am Co-Investors Iv, L.p. | 501 2Nd Street, Suite 350 San Francisco, CA 94107 | No | No | No | Yes | |
1598549 | J. Andrew Schwab | 501 2Nd Street, Suite 350 San Francisco, CA 94107 | No | No | No | Yes |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2019-06-21 | 240,000 | $22.20 | 2,267,797 | No | 4 | S | Indirect | See footote |
Common Stock | Disposition | 2019-06-21 | 10,000 | $22.20 | 94,489 | No | 4 | S | Indirect | See footote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See footote |
No | 4 | S | Indirect | See footote |
Footnotes
- These securities are held by by 5AM Ventures IV, L.P. ("Ventures IV"). 5AM Partners IV, LLC ("Partners IV") is the sole general partner of Ventures IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners IV, and have shared voting and investment power over the shares beneficially owned by Ventures IV. Each of Partners IV, Dr. Diekman, Mr. Schwab, and Dr. Rocklage disclaims beneficial ownership of such shares except to the extent of its or their pecuniary interest therein.
- These securities are held by 5AM Co-Investors IV, L.P. ("Co-Investors IV"). Partners IV is the sole general partner of Co-Investors IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Co-Investors IV, and have shared voting and investment power over the shares beneficially owned by Co-Investors IV. Each of Partners IV, Dr. Diekman, Mr. Schwab, and Dr. Rocklage disclaims beneficial ownership of such shares except to the extent of its or their pecuniary interest therein.